Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H30N4O6 |
Molecular Weight | 446.4968 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
InChI
InChIKey=LEHPJMKVGFPSSP-ZQINRCPSSA-N
InChI=1S/C22H30N4O6/c1-3-12(2)19(23)21(30)25-16(8-9-18(27)28)20(29)26-17(22(31)32)10-13-11-24-15-7-5-4-6-14(13)15/h4-7,11-12,16-17,19,24H,3,8-10,23H2,1-2H3,(H,25,30)(H,26,29)(H,27,28)(H,31,32)/t12-,16-,17-,19-/m0/s1
Molecular Formula | C22H30N4O6 |
Molecular Weight | 446.4968 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:32:38 GMT 2023
by
admin
on
Sat Dec 16 11:32:38 GMT 2023
|
Record UNII |
0E7F7I1471
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9846400
Created by
admin on Sat Dec 16 11:32:38 GMT 2023 , Edited by admin on Sat Dec 16 11:32:38 GMT 2023
|
PRIMARY | |||
|
182295-87-0
Created by
admin on Sat Dec 16 11:32:38 GMT 2023 , Edited by admin on Sat Dec 16 11:32:38 GMT 2023
|
PRIMARY | |||
|
0E7F7I1471
Created by
admin on Sat Dec 16 11:32:38 GMT 2023 , Edited by admin on Sat Dec 16 11:32:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
||
|
ACTIVE MOIETY |
Stemokin - a drug to stimulate hematopoiesis and immunity after exposure to chemotherapy and radiation, as well as for the treatment of secondary immunodeficiency conditions. On the market in Russia.
|